| Product Code: ETC8891919 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Pharmacogenetic Testing Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Portugal Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Portugal Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Portugal Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Portugal Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Portugal Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Portugal Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Portugal Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Portugal Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Portugal Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about the benefits of pharmacogenetic testing |
4.2.2 Growing demand for personalized medicine and precision healthcare |
4.2.3 Government initiatives promoting genetic testing and personalized medicine |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenetic testing |
4.3.2 Limited reimbursement policies for genetic testing in Portugal |
4.3.3 Lack of standardized guidelines and regulations for pharmacogenetic testing |
5 Portugal Pharmacogenetic Testing Market Trends |
6 Portugal Pharmacogenetic Testing Market, By Types |
6.1 Portugal Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Portugal Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Portugal Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Portugal Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Portugal Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Portugal Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Portugal Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Portugal Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Portugal Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Portugal Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Portugal Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Portugal Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Portugal Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Portugal Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Portugal Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Portugal Pharmacogenetic Testing Market Export to Major Countries |
7.2 Portugal Pharmacogenetic Testing Market Imports from Major Countries |
8 Portugal Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers in Portugal |
8.2 Number of research studies and publications related to pharmacogenetic testing in Portugal |
8.3 Percentage of healthcare facilities offering pharmacogenetic testing services |
9 Portugal Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Portugal Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Portugal Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Portugal Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Portugal Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Portugal Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Portugal Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Portugal Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Portugal Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Portugal Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Portugal Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here